Do You Really Need to Finish Every Antibiotic? What Science Says

Decades of “finish your antibiotics” advice has left a deep mark on the American public, and a major new survey shows just how hard that message is to shake. Most adults in the United States still prefer longer antibiotic courses for bacterial respiratory infections, even as medical experts have increasingly moved toward recommending shorter ones for conditions like pneumonia. The disconnect between what patients want and what doctors now know to be best for these kinds of infections could have real consequences for both individual health and the broader fight against drug-resistant bacteria.

Since penicillin was first used in the 1940s, doctors and public health campaigns hammered home the same message: always finish every pill in your antibiotic prescription, even if you feel better. That advice made intuitive sense. But over 120 clinical trials have since shown that, for many common bacterial infections, shorter antibiotic courses are often just as effective and safer than longer ones, and no more likely to contribute to antibiotic resistance. That broad body of evidence has pushed doctors toward shorter courses for respiratory infections like pneumonia. Even so, a new national online survey of 1,475 American adults, published in the journal Open Forum Infectious Diseases, found that public beliefs have not caught up.

Roughly 60% of survey respondents said they would prefer a longer antibiotic course of seven days or more when being treated for a bacterial respiratory infection. Meanwhile, about 88% agreed it is important to always finish a prescribed course of antibiotics, even if they start feeling better. These findings point to a major gap between current medical guidance for common bacterial respiratory infections and what everyday Americans actually believe and want.

How the Survey on Antibiotic Course Length Was Done

Researchers recruited 1,475 English-reading American adults through an online survey platform between March and April 2024. Participants were at least 18 years old and came from across the country. About half identified as female, the average age was around 52, and respondents represented a range of racial and ethnic backgrounds. After completing the survey, 15 respondents were removed for finishing too quickly and 69 more were cut because their written answers raised questions about the quality of their responses.

Participants were asked which antibiotic course length they would feel most comfortable taking for a bacterial respiratory infection: a short course of three to five days or a longer one of seven days or more. They were also asked about their beliefs regarding antibiotic adherence, their comfort with updated medical advice, how much they trusted their doctors, and whether they had ever been told, either by a healthcare provider or through public health messaging, to always finish their antibiotics.

What People Believe About Antibiotics and Why

Most respondents who preferred longer antibiotic courses said they equated duration with effectiveness. In their minds, a longer course meant the infection was being treated more thoroughly, a kind of “better safe than sorry” logic. Many explicitly connected this belief to advice they had personally received from a doctor.

A full 76% of respondents said a medical professional had told them to always finish a course of antibiotics, and among those, three-quarters said that professional was a physician such as a primary care doctor. By comparison, about 61% recalled hearing the same message from a public health source, such as a poster or commercial.

Only 17.5% of respondents had ever been told by a provider that they could stop taking antibiotics once they started feeling better. Yet despite that low exposure, 59.2% said they would feel at least somewhat comfortable if a clinician gave them that kind of advice for a bacterial respiratory infection. And 57.4% said they would still view that clinician as at least somewhat competent. That matters, because it points to a real opening for doctors to shift patient expectations around bacterial respiratory infections, even when the advice feels unfamiliar.

Respondents who preferred shorter antibiotic courses described different motivations. They generally preferred avoiding unnecessary medication, worried about side effects, and were more familiar with receiving shorter durations when antibiotics had been prescribed to them in the past, or held a general belief that fewer pills are better.

Who Is Most Likely to Want Longer Antibiotic Treatment

The analysis showed that respondents who preferred longer antibiotic courses tended to be older, trusted their doctor’s advice about antibiotic duration more completely, and were more likely to have been told by a medical professional to always finish their prescription. They also tended to worry less about side effects from antibiotics. More than 40% of all respondents reported little to no concern about antibiotic side effects, and that attitude was linked to a preference for longer treatment.

People who preferred longer courses were also less comfortable with being told to stop antibiotics when they felt better, and were more likely to view a clinician giving that advice as less competent.

What This Means for Doctors and Public Health

Researchers say their findings carry clear lessons for how healthcare providers and public health officials should talk about bacterial respiratory infections and antibiotic treatment going forward. One main takeaway is that simple, catchy slogans like “always finish your course” can stick around long after the science has moved on, making them difficult to walk back without causing confusion or distrust.

Rather than replacing one slogan with another, which risks repeating the same problem, researchers suggest that clinicians take time to explain their reasoning when prescribing shorter antibiotic courses for bacterial respiratory infections, framing the updated guidance as a reflection of scientific progress rather than a contradiction. They also emphasize that shorter courses are appropriate only in specific clinical contexts decided by the treating clinician, not as a rule for patients to apply on their own, and that clear, context-specific communication is more valuable than a blanket new slogan. Since respondents showed high levels of trust in their doctors, with about 93% saying they trusted their doctor’s advice on antibiotic length, that relationship could be a powerful tool for updating patient expectations.

Researchers also suggest that communicating the real risks of unnecessary antibiotic use, including side effects and broader harm to public health, might help people make more informed decisions. Normalizing shorter courses over time for appropriate infections, by simply prescribing them more consistently and explaining why, could make patients more comfortable with them through familiarity alone.

Decades of well-meaning public health messaging convinced Americans that finishing every antibiotic pill was a matter of personal safety and social responsibility. Undoing that belief will take more than updated guidelines circulated among doctors. It will require clear, honest conversations between patients and providers, and a willingness to treat changing medical advice not as a failure of past guidance, but as a sign that science is doing its job.

Disclaimer: This article summarizes findings from a single peer-reviewed survey study and is intended for general information only. It is not medical advice. Antibiotic treatment length depends on the specific infection and should be determined by a qualified healthcare provider. Patients should always follow the duration their own clinician recommends and should not start, stop, or change a prescription on their own.

---